Opportunities and challenges of immunotherapy for dMMR/ MSI-H colorectal cancer

被引：0
|
作者：
Zhang, Qi [1 ]
Li, Jian [2 ]
Shen, Lin [2 ]
Li, Yongsheng [1 ]
Wang, Xicheng [2 ]
机构：
[1] Chongqing Univ, Canc Hosp, Dept Med Oncol, Chongqing 400030, Peoples R China
[2] Peking Univ, Beijing Canc Hosp & Inst, Dept Gastrointestinal Oncol, Lab Carcinogenesis & Translat Res,Sch Oncol,Minist, Beijing 100142, Peoples R China
来源：
CANCER BIOLOGY & MEDICINE | 2023年 / 20卷 / 10期
关键词：
MISMATCH REPAIR DEFICIENCY; RECTAL-CANCER; MICROENVIRONMENT; BLOCKADE;
D O I：
10.20892/j.issn.2095-3941.2023.0240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：706 / 712
页数：7
相关论文
共 50 条
  • [1] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    Cancer Biology & Medicine, 2023, 20 (10) : 706 - 712
  • [2] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    Cancer Biology & Medicine, 2023, (10) : 706 - 712
  • [3] Challenges and Therapeutic Opportunities in the dMMR/MSI-H Colorectal Cancer Landscape
    Mulet-Margalef, Nuria
    Linares, Jenniffer
    Badia-Ramentol, Jordi
    Jimeno, Mireya
    Monte, Carolina Sanz
    Mozo, Jose Luis Manzano
    Calon, Alexandre
    CANCERS, 2023, 15 (04)
  • [4] Immunotherapy Promising for Metastatic MSI-H/dMMR Colorectal Cancer
    Yarden, Ronit
    ONCOLOGY-NEW YORK, 2019, 33 (05): : 179 - 179
  • [5] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [6] Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
    Zhang, Xuan
    Wu, Tao
    Cai, Xinyi
    Dong, Jianhua
    Xia, Cuifeng
    Zhou, Yongchun
    Ding, Rong
    Yang, Renfang
    Tan, Jing
    Zhang, Lijuan
    Zhang, Ya
    Wang, Yuqin
    Dong, Chao
    Li, Yunfeng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review
    Xiao, Binyi
    Yu, Jiehai
    Ding, Pei-Rong
    CLINICS IN COLON AND RECTAL SURGERY, 2023, 36 (06) : 378 - 384
  • [8] MSI-H/dMMR and cancer immunotherapy: current state and future implications
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (06): : 345 - 347
  • [9] NIVOLUMAB HAS ANTITUMOR ACTIVITY IN DMMR/MSI-H COLORECTAL CANCER
    CANCER DISCOVERY, 2017, 7 (09) : 930 - 930
  • [10] Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer
    Inamori, Koji
    Togashi, Yosuke
    Fukuoka, Shota
    Akagi, Kiwamu
    Ogasawara, Kouetsu
    Irie, Takuma
    Motooka, Daisuke
    Kobayashi, Yoichi
    Sugiyama, Daisuke
    Kojima, Motohiro
    Shiiya, Norihiko
    Nakamura, Shota
    Maruyama, Shoichi
    Suzuki, Yutaka
    Ito, Masaaki
    Nishikawa, Hiroyoshi
    JCI INSIGHT, 2021, 6 (09)
12345